Posts
March 10 2024
Danimer Scientific, Inc. announced the closing of its Registered Direct offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
March 09 2024
ASLAN Pharmaceuticals Limited announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
March 08 2024
Vivani Medical, Inc., an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, announced the pricing of its registered direct offering in the amount of $15,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.
March 08 2024
Cadrenal Therapeutics, Inc. announced the commencement of its At The Market Offering in the amount of $5,143,730. EG&S acted as counsel to the Sales Agent.
March 05 2024
Intelligent Bio Solutions Inc. announced the closing of its Private Placement in the amount of $10,100,000. EG&S acted as counsel to the Placement Agent.
March 05 2024
David R. Rothfeld, who leads the Firm’s Traditional Law Practice and is Co-chair of the Firm’s Hospitality Practice Group, was a participant on Cornell’s Center for Innovative Hospitality & Labor Relations program on Issues in Traditional Labor Law held in Hollywood, Florida on March 1, 2024.
March 04 2024
Client Alert: CDC Drops 5-Day COVID Isolation Guidelines
On March 1, 2024, the Centers for Disease Control (“CDC”) updated its guidelines for individuals infected with COVID-19, unifying its isolation recommendations for those with the flu, RSV and COVID-19, and recommending affected individuals isolate until (1) they have been fever-free for 24 hours without the assistance of medication and (2) their symptoms are improving.
Click here to read the alert.
March 04 2024
SINTX Technologies, Inc. announced the closing of its Public Offering in the amount of $1,300,000. EG&S acted as counsel to the Placement Agent.